期刊文献+

CD100与心肌梗塞关系的临床研究

Clinical research of the relationship between CD100 and AMI
原文传递
导出
摘要 目的探讨心肌梗塞患者外周血CD100变化,及其与血脂、心肌梗塞标志物浓度变化的关系。方法收集102例AMI患者为AMI组,另收集87例健康体检者为对照组,采用流式细胞术检测2组对象外周血细胞CD100的表达,运用化学比色法检测血脂、化学发光法测定心肌梗塞标志物浓度。结果与对照组相比,AMI组患者外周血CD3+细胞CD100的表达显著升高,差异有统计学意义(P<0.05);且血脂及心肌梗塞标志物浓度明显升高,差异有统计学意义(P<0.05)。结论心肌梗塞患者外周血CD100表达异常,与血脂、心肌梗塞标志物浓度变化呈显著正相关。 Objective To investigate the CD100 expression of blood cells in the acute myocardial infarction( AMI) patients and the its relationship among levels of CD100,blood fat and serological markers of AMI. Methods 87 normal control cases and 102 AMI cases( G2 group) were collected as the control group and the AMI group. Flow cytometry was used to detect the expression of CD100 on the peripheral blood cells of the two groups. Blood lipid was detected by chemical colorimetry and the concentration of myocardial infarction markers was determined by chemiluminescence. Results Compared with the control group,the expression of CD100 in peripheral blood CD3~+ cells in AMI group significantly increased,with the differences statistically significant( P 〈0. 05),and the concentrations of lipid and myocardial infarction markers significantly increased,with the differences statistically significant( P 〈0. 05). Conclusion The expression of blood cells CD100 is abnormal in the AMI patients.The level of CD100 was positively correlated with the concentrations of blood fat and serological markers of AMI.
出处 《中国卫生检验杂志》 CAS 2018年第3期294-296,共3页 Chinese Journal of Health Laboratory Technology
基金 江西省卫生厅课题(20164041)
关键词 CD100 血脂 心肌梗塞标志物 心肌梗塞 CD100 Blood fat Serological markers of AMI Acute myocardial infarction
  • 相关文献

参考文献4

二级参考文献29

  • 1罗军,刘云兵.心肌肌钙蛋白在心血管病诊治中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(1):38-39. 被引量:37
  • 2郭占军,赵华,郭爱芹,杨焕云.心肌肌钙蛋白I测定及其在急性冠状动脉综合征中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(6):364-366. 被引量:30
  • 3Tucker JF, CollinsRA, Anderson AJ ,et al. Value of serialmyglobinlevels in the early diagnosis ofpatients admitted for acutemyocardialinfarction [ J ]. Ann Emerg Med, 1994,24 (4) :704 - 708.
  • 4Mallat Z, Corbaz A, Scoazec A, et al. Expression of interleukin - 18 in human at herosclerotic plaques and relation to plaque instability [J]. Circulation,2001,4(14) :1598 - 1600.
  • 5Szymanski FM, Grabowski M, Hrynkiewicz A, et al. Usefulness of my- ocardial necrosis triad markers for predicting 4 - year mortality in pa- tients with suspected acute coronary syndrome [ J ]. ACTA CARDIO- LOGICA, 2008, 63(4) : 473 -477.
  • 6Rawles J. Magnitude of benefit from earlier thrombolytic treatment in a- cute myocardial infarction: new evidence from Grampian region early anistreplase trial [ J ]. Rr Med, 1996,312 (7025) : 212 - 216.
  • 7Schwerrdt H, Ozbdk C, Frohieffer H, et al. Optimized function for de- termining time to peak creatine kinase and creatine kinase - MB as non - invasive reperfusion indicators after thrombolytic therapy in acute my- ocardial infarction[J]. Cardiovasc Rec, 1990,24(4) :328 -334.
  • 8Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines : clin- ical characteristics and utilization of biochemical markers in acute coronary syndromes [ J ]. Circulation, 2007, 115 ( 13 ) : 356.
  • 9Mueller M, Bicner M, Vafaie M, et al. Absolute and relative ki- netic changes of high - sensitivity cardiac troponin T in acute coro- nary syndrome and in patients with increased troponin in the ab- sence of acute coronary syndrome [ J]. Clin Chem, 2012, 58 (1) : 209 -218.
  • 10Fisman EZ, Bendedy M, Esper RJ, et al. Interleukin -6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction[ J]. Am J Cardiol, 2006, 98 (l): 14-18.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部